Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Genetics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06046131
What this trial is testing

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

Who this might be right for
Prostatic NeoplasmAdenocarcinomaNeoplasm Recurrence+1 more
Centre Hospitalier Universitaire de la Guadeloupe 3,000
Early research (Phase 1)Active Not RecruitingNCT03618381
What this trial is testing

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+13 more
Seattle Children's Hospital 44
Not applicableUnknownNCT03979612
What this trial is testing

Evaluation of the Adhesion to the GENEPY Network

Who this might be right for
Hereditary Cancer SyndromeHereditary Breast and Ovarian CancerHereditary Colorectal Endometrial Cancer Syndrome
Institut Claudius Regaud 450
Testing effectiveness (Phase 2)Study completedNCT01289912
What this trial is testing

Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)

Who this might be right for
Tuberous Sclerosis Complex
Mustafa Sahin 52
Large-scale testing (Phase 3)Study completedNCT01190930
What this trial is testing

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Lymphoblastic LymphomaAnn Arbor Stage I B Lymphoblastic Lymphoma+7 more
Children's Oncology Group 9,350
Testing effectiveness (Phase 2)UnknownNCT01954693
What this trial is testing

Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis

Who this might be right for
Tuberous Sclerosis
Cardiff University 48
Not applicableLooking for participantsNCT05927519
What this trial is testing

Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study

Who this might be right for
Obesity, MorbidIntubation; Difficult or FailedVideo Laryngoscope+1 more
Kocaeli University 80
Not applicableLooking for participantsNCT02420067
What this trial is testing

Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients

Who this might be right for
Von Hippel-Lindau Disease
Marie Luise Bisgaard, MD 380
Not applicableEnded earlyNCT00578292
What this trial is testing

Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO

Who this might be right for
Thalassemia
Baylor College of Medicine 10
Early research (Phase 1)Study completedNCT01048892
What this trial is testing

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Who this might be right for
Adrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more
Children's Oncology Group 22
Not applicableStudy completedNCT01604564
What this trial is testing

Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients

Who this might be right for
Colitis,UlcerativeAdenomatous Polyposis ColiReservoir, Ileoanal
Universitaire Ziekenhuizen KU Leuven 207
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Not applicableUnknownNCT01688232
What this trial is testing

The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer

Who this might be right for
Colorectal CancerSurgical Resection of the Colorectal Tumor
Assistance Publique - Hôpitaux de Paris 459
Testing effectiveness (Phase 2)Looking for participantsNCT07237100
What this trial is testing

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

Who this might be right for
Advanced Unresectable MelanomaMetastatic Melanoma
Kevin Kim, MD 10
Early research (Phase 1)Study completedNCT01664000
What this trial is testing

A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Cellceutix Corporation 48
Not applicableStudy completedNCT00003793
What this trial is testing

Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma

Who this might be right for
LeukemiaMyelodysplastic SyndromesSarcoma
Children's Oncology Group 294
Testing effectiveness (Phase 2)Study completedNCT00410514
What this trial is testing

Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

Who this might be right for
Lower Urinary Tract SymptomsBladder Outlet Obstruction
Astellas Pharma Inc 200
Not applicableUnknownNCT03963700
What this trial is testing

Tumor Characteristics in Patients With Paraneoplastic Neurological Syndromes (PNS)

Who this might be right for
CancerParaneoplastic SyndromesNeurologic Disorder+2 more
Hospices Civils de Lyon 980
Testing effectiveness (Phase 2)Looking for participantsNCT07463599
What this trial is testing

Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Carcinoma (mCRC)Colorectal Cancer (CRC)Adenomatous Polyposis Coli (APC) Gene Mutation+1 more
HonorHealth Research Institute 126
Testing effectiveness (Phase 2)WithdrawnNCT04158700
What this trial is testing

LY3200882 and Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company
Next Page